Skip to main content

NANOPARTICULAS PARA CONTRASTE POSITIVO EN IMAGEN POR RESONANCIA MAGNETICA IN VIVO: APLICACION AL DIAGNOSTICO Y CARACTERIZACION DE LA ATEROSCLEROSIS

PID2019-104059RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis

  • Pellico, Juan
  • Fernández-Barahona, Irene
  • Ruiz-Cabello, Jesús
  • Gutiérrez, Lucía
  • Muñoz-Hernando, María
  • Sánchez-Guisado, María J.
  • Aiestaran-ZelaiaI, rati
  • Martínez-Parra, Lydia
  • Rodríguez, Ignacio
  • Bentzon, Jacob
  • Herranz, Fernando
Vascular microcalcifications are associated with atherosclerosis plaque instability and, therefore, to increased mortality. Because of this key role, several imaging probes have been developed for their in vivo identification. Among them, [18F]FNa is the gold standard, showing a large uptake in the whole skeleton by positron emission tomography. Here, we push the field toward the combined anatomical and functional early characterization of atherosclerosis. For this, we have developed hydroxyapatite (HAP)-multitag, a bisphosphonate- functionalized 68Ga core-doped magnetic nanoparticle showing high affinity toward most common calcium salts present in microcalcifications, particularly HAP. We characterized this interaction in vitro and in vivo, showing a massive uptake in the atherosclerotic lesion identified by positron emission tomography (PET) and positive contrast magnetic resonance imaging (MRI). In addition, this accumulation was found to be dependent on the calcification progression, with a maximum uptake in the microcalcification stage. These results confirmed the ability of HAP-multitag to identify vascular calcifications by PET/(T1)MRI during the vulnerable stages of the plaque progression., This work was supported by the Spanish Ministry of Science (grant nos. SAF2016-79593-P, RED2018-102469-T, and PID2019-104059RB-I00) and from the Gobierno Vasco, Dpto. Industria, Innovación, Comercio y Turismo under the ELKARTEK Program (grant no. KK-2019/bmG19). JR-C received funding from the BBVA Foundation (Ayudas a Equipos de investigación científica Biomedicina 2018). The CNIC is supported by the MICINN and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MICINN award SEV-2015-0505). CIC biomaGUNE is supported by the Maria de Maeztu Units of Excellence Program from the Spanish State Research Agencygrant no. MDM-2017-0720. L.G. acknowledges financial support from the Ramón y Cajal program (RYC-2014-15512 0), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems

  • Arroyo-Urea, Eva María
  • Muñoz-Hernando, María
  • Leo-Barriga, Marta
  • Herranz, Fernando
  • González-Paredes, Ana
Nanoemulsions (NE) are lipid nanocarriers that can efficiently load hydrophobic active compounds, like palmitoyl-L-carnitine (pC), used here as model molecule. The use of design of experiments (DoE) approach is a useful tool to develop NEs with optimized properties, requiring less experiments compared to trial-and-error approach. In this work, NE were prepared by the solvent injection technique and DoE using a two-level fractional factorial design (FFD) as model was implemented for designing pC-loaded NE. NEs were fully characterized by a combination of techniques, studying its stability, scalability, pC entrapment and loading capacity and biodistribution, which was studied ex-vivo after injection of fluorescent NEs in mice. We selected the optimal composition for NE, named pC-NE, after analysis of four variables using DoE. pC-NE incorporated pC in a very efficient manner, with high entrapment efficiency (EE) and loading capacity. pC-NE did not change its initial colloidal properties stored at 4 °C in water during 120 days, nor in buffers with different pH values (5.3 and 7.4) during 30 days. Moreover, the scalability process did not affect NE properties and stability profile. Finally, biodistribution study showed that pC-NE formulation was predominantly concentrated in the liver, with minimal accumulation in spleen, stomach, and kidneys., This work was supported by Atracción de Talento (Modalidad 1) program from Comunidad de Madrid (Spain) (Reference 2019-T1/IND-12906) and Spanish Ministry of Science (Grants nos. PID2019-104059RB-I00 and PDC2022-133493-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque

  • Martínez-Parra, Lydia
  • Piñol-Cancer, Marina
  • Sanchez-Cano, Carlos
  • Miguel-Coello, Ana Beatriz
  • Di Silvio, Desiré
  • Gómez, Ana M.
  • Uriel, Clara
  • Plaza-García, S.
  • Gallego, M.
  • Pazos, Raquel
  • Groult, Hugo
  • Jeannin, Marc
  • Geraki, Kalotina
  • Fernández-Méndez, Laura
  • Urkola-Arsuaga, Ainhize
  • Sánchez-Guisado, Mª Jesús
  • Carrillo-Romero, Juliana
  • Parak, Wolfgang J.
  • Prato, Maurizio
  • Herranz, Fernando
  • Ruíz-Cabello, Jesús
  • Carregal-Romero, Susana
therosclerosis is a complex disease that can lead to life-threatening events, such as myocardial infarction and ischemic stroke. Despite the severity of this disease, diagnosing plaque vulnerability remains challenging due to the lack of effective diagnostic tools. Conventional diagnostic protocols lack specificity and fail to predict the type of atherosclerotic lesion and the risk of plaque rupture. To address this issue, technologies are emerging, such as noninvasive medical imaging of atherosclerotic plaque with customized nanotechnological solutions. Modulating the biological interactions and contrast of nanoparticles in various imaging techniques, including magnetic resonance imaging, is possible through the careful design of their physicochemical properties. However, few examples of comparative studies between nanoparticles targeting different hallmarks of atherosclerosis exist to provide information about the plaque development stage. Our work demonstrates that Gd (III)-doped amorphous calcium carbonate nanoparticles are an effective tool for these comparative studies due to their high magnetic resonance contrast and physicochemical properties. In an animal model of atherosclerosis, we compare the imaging performance of three types of nanoparticles: bare amorphous calcium carbonate and those functionalized with the ligands alendronate (for micro- calcification targeting) and trimannose (for inflammation targeting). Our study provides useful insights into ligand-mediated targeted imaging of atherosclerosis through a combination of in vivo imaging, ex vivo tissue analysis, and in vitro targeting experiments., We acknowledge M. Spuch for his scientific drawings and the Basque Government for the R&D Project in Health (grant number 2022333041). S.C.R. acknowledges the Spanish Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI) Grant PID2019-106139RA-100 funded by MCIN/AEI/10.13039/501100011033 and the Ramon y Cajal Grant RYC2020-030241-I. C.S.C. acknowledges financial support from the Spanish State Research Agency (grant PID2020-118176RJ-I100), and the Gipuzkoa Foru Aldundia (Gipuzkoa Fellows program; grant number 2019-FELL- 000018-01/62/2019). This work was performed under the Severo Ochoa Centers of Excellence Program of the Spanish State Research Agency − Grant No. CEX2018-000867-S (DIPC). SXRF analysis was carried out with the support of Diamond Light Source, beamline I18 (proposal SP27720). J.R.C. is funded by MCIN/AEI/10.13039/501100011033 (PID2021-123238OB-I00) and from La Caixa Foundation (Health Research Call 2020: HR20-00075). A.M.G. and C.U. acknowledge the Spanish Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI) Grant: PID2021-122504NB-I00 funded by MCIN/AEI/10.13039/ 501100011033 and by “ERDF A way of making Europe. W.J.P. acknowledges funding from the Cluster of Excellence “Advanced Imaging of Matter” of the Deutsche Forschungsge- meinschaft (DFG) - EXC 2056 - project ID 390715994. F.H. acknowledges MCIN (PID2019-104059RB-I00) and M.J.S.G. the Spanish Ministerio de Educación y Formación Profesional (PRE2018-083691)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Radiolabeled Iron Oxide Nanomaterials for Multimodal Nuclear Imaging and Positive Contrast Magnetic Resonance Imaging (MRI): A Review

  • Pellico, Juan
  • Ruíz-Cabello, Jesús
  • Herranz, Fernando
Iron oxide nanoparticles (IONP) have been hailed as potential game-changers in biomedical imaging owing to their biocompatibility and size-dependent properties. One area where IONP has shown particular promise is magnetic resonance imaging (MRI), which traditionally uses superparamagnetic nanomaterials to produce negative contrast that darkens the tissues where nanoparticles accumulates. Unfortunately, this hypointense signal is a major drawback for clinical applications because it can make it difficult to identify the accumulated probes. As a result, researchers are exploring alternative options that can incorporate the advantages of IONP while also possessing valuable properties for molecular imaging. To achieve this goal, the most effective method involves not only utilizing positive contrast in MRI applications but also combining IONP with the unparalleled sensitivity of nuclear imaging techniques, for example, using radioisotopes to create PET/(T)MRI multimodal probes. To create such probes, various factors must be considered, including the radiolabeling strategy employed and overall complexity of the final nanoprobe. These nanoradiomaterials offer novel possibilities that span beyond the molecular imaging field, showing potential for the development of radiopharmaceuticals and theranostics., This study was supported by the Spanish Ministry of Science and Innovation (PID2019-104059RB-I00, PDC2022-133493- I00, PID2021-123238OB-I00), Comunidad de Madrid (S2022/BMD-7333) and La Caixa Foundation (Health Research Call 2020: HR20-00075).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis

  • Muñoz-Hernando, María
  • Nogales, P.
  • Fernández-Barahona, Irene
  • Ruiz-Cabello, J.
  • Bentzon, J. F.
  • Herranz, Fernando
Atherosclerosis, a leading cause of cardiovascular diseases requires approaches to enhance disease monitoring and treatment. Nanoparticles offer promising potential in this area by being customisable to target components or molecular processes within plaques, while carrying diagnostic and therapeutic agents. However, the number of biomarkers available to target this disease is limited. This study investigated the use of sphingomyelin-based nanomicelles triggered by sphingomyelinase (SMase) in atherosclerotic plaques. Accumulation of iron oxide-based nanomicelles in the plaque was demonstrated by fluorescence, MR imaging and electron microscopy. These findings demonstrate the possibility of utilising SMase as a mechanism to retain nanoprobes within plaques, thus opening up possibilities for future therapeutic interventions., This study was supported by grants from the Ministerio de Economía, Industria y Competitividad (MEIC) with cofunding from the European Regional Development Fund (PID2019- 108568RB-I00) and Ministerio de Ciencia e Innovación (PID2019-104059RB-100, PDC2022-133493-100, RED2022- 134299-T), Comunidad de Madrid (P2022/BMD-7333) and La Caixa Health Research Programme (HR20-00075, AtheroConvergence). CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Periodic table screening for enhanced positive contrast in MRI and in vivo uptake in glioblastoma

  • Herraiz-Pérez, Aitor
  • Morales, María Del Puerto
  • Martínez-Parra, Lydia
  • Arias-Ramos, Nuria
  • López-Larrubia, Pilar
  • Gutiérrez, Lucía
  • Mejías, Jesús
  • Díaz-Ufano, Carlos
  • Ruíz-Cabello, Jesús
  • Herranz, Fernando
The quest for nanomaterial-based imaging probes that can provide positive contrast in MRI is fueled by the necessity of developing novel diagnostic applications with potential for clinical translation that current gold standard probes cannot provide. Although interest in nanomaterials for positive contrast has increased in recent years, their study is less developed than that of traditional negative contrast probes in MRI. In our search for new magnetic materials with enhanced features as positive contrast probes for MRI, we decided to explore the chemical space to comprehensively analyze the effects of different metals on the performance of iron oxide nanomaterials already able to provide positive contrast in MRI. To this end, we synthesized 30 different iron oxide-based nanomaterials. Thorough characterization was performed, including multivariate analysis, to study the effect of different variables on their relaxometric properties. Based on these results, we identified the best combination of metals for in vivo imaging and tested them in different experiments. First, we tested its performance on magnetic resonance angiography using a concentration ten times lower than that clinically approved for Gd. Finally, we studied the capability of these nanomaterials to cross the affected blood–brain barrier in a glioblastoma model. The results showed that the selected nanomaterials provided excellent positive contrast at large magnetic field and were able to accumulate at the tumor site, highlighting the affected tissue., This study was supported by a grant for predoctoral contracts for the training of PhD students from the Spanish Ministry of Science and Innovation (grant number PRE2020-091870), associated with the National Plan project PID2019-104059RB-100. We acknowledge funding from the Spanish Ministry of Science and Innovation (PID2021-123238OB-100, PDC2022-133493-100, RED2022-134299-T), La Caixa Foundation (Health Research Call 2020: HR20-00075), the Basque Government, R&D Projects in Health (Grant no. 2022333041) and Comunidad de Madrid (P2022/BMD-7333). Conexión Nanomedicina CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Design of tunable hyaluronic acid and O′-carboxymethyl chitosan formulations for the minimally invasive delivery of multifunctional therapies targeting rheumatoid arthritis

  • Fernández-Villa, Daniel
  • Herraiz-Pérez, Aitor
  • De Wit, K.
  • Herranz, Fernando
  • Aguilar, María Rosa
  • Rojo, Luis
This paper is dedicated to the memory of Blanca Vázquez-Lasa, who participated in the conceptualization and preliminary studies of this work, but lamentably passed away on 31st January 2023., The development of injectable, dual-component formulations based on natural-based polysaccharides is a promising strategy for the localized treatment of rheumatoid arthritis (RA). In the present study, biomimetic formulations consisting of aldehyde-functionalized hyaluronic acid (AHA) and O-carboxymethyl chitosan (OCC) were developed, presenting rapid in situ gelation rates and finely tunable physicochemical properties. These two properties allowed for the controlled delivery of anti-inflammatory, antioxidant, and pro-regenerative agents (i.e., strontium-methotrexate (SrMTX) and europium-tannic acid nanocomplexes (EuTA NCs), making them suitable for application in in vivo RA-models. Biological analyses demonstrated the system's cytocompatibility and its ability to modulate the activity of human articular chondrocytes at the secretome level and scavenge nitric oxide (NO). Moreover, the loaded cargoes not only extended the anti-inflammatory properties of the formulation but also the radiolabeling of EuTA NCs with Ga allowed the visualization of the gel by positron emission tomography (PET). Overall, this work presents the design and in vitro evaluation of an easily modulable polymeric system that allows the in situ release of a multifunctional therapy with promising perspectives for RA treatment., This research has been funded by the Spanish MICIU (PID2020-114086RB-I00, PID2023-149301OB-I00, PID2019-104059RB-I00, PDC2022-133493- 100) and Comunidad Autónoma de Madrid (S2022/BMD-7406, S2022/ BMD-7333). D. F.-V. is financially supported by a predoctoral program MICIU FPU18/04683. The authors would like to acknowledge the sup- port of PTI-SusPlast+ CSIC, Nanomedicine CSIC and the NMR service team at the National Center for Organic Chemistry (CENQUIOR-CSIC) for their technical support and expertise
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Targeted PET Imaging of Atherosclerosis via Low-Density Lipoprotein Click Chemistry with Nanoparticles

  • Nogales, Paula
  • Muñoz-Hernando, Maria
  • Bentzon, Jacob F.
  • Herranz, Fernando
  • Pellico, Juan
Low-density lipoprotein (LDL) plays a central role in the development of atherosclerosis, making its detection critical for cardiovascular disease management. Radionuclide imaging of LDL offers distinct advantages over other modalities but remains limited by poor specificity and the need for long-lived isotopes. We present a click chemistry-based PET imaging strategy using gallium-68 (68Ga), a short-lived radionuclide, for the specific detection of LDL accumulation in atherosclerotic plaques. The approach relies on a two- step inverse electron-demand Diels−Alder reaction between trans-cyclooctene (TCO)-modified LDL and tetrazine-functionalized iron oxide nanoparticles radiolabeled with 68Ga. In vivo PET/CT imaging in LDL receptor-deficient (LDLr−/−) mice showed selective uptake of the nanoparticles in athero- sclerotic lesions, with minimal signal in wild-type controls. This method demonstrated high specificity and sensitivity, while reducing background signal and radiation exposure. Our results support the potential of this approach as a noninvasive and translatable platform for early diagnosis and risk assessment in cardiovascular disease., The authors acknowledge financial support through the Spanish Ministry of Science and Innovation (PDC2022- 133493-100, RED2022-134299-T, PID2019-104059RB-100 and PID2024-155894OA-100), Comunidad de Madrid (P2022/BMD-7333) and Conexion Nanomedicina CSIC. J. P. acknowledges financial support from the Ramon y Cajal program (Grant No. RYC2023-043157-I) funded by the MCIN/AEI/10.13039/501100011033 and the ESF “Investing in your future”. We also acknowledge financial support from Ministerio de Economía, Industria y Competitividad (MEIC) with cofunding from the European Regional Development Fund (ERDF) [grants PI2019-108568RB-I00 to J.F.B., BES- 2016-076633 to P.N.]. The Centro Nacional de Investiga- ciones Cardiovasculares (CNIC) is supported by the Instituto de Salud Carlos III (ISCIII) and the Ministerio de Ciencia e Innovación (MICIN). The institute of Materials Science of Barcelona and the Pro CNIC Foundation are Severo Ochoa Center of Excellence in R&D (CEX2023-001263-S and CEX2020001041-S) funded by MCIN/AEI/10.13039/ 501100011033 and by FEDER, “A way of making Europe”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A single-step radiolabeling strategy for PET, SPECT, and therapeutic radionuclides using nanoparticles as a universal chelator

  • Herraiz-Pérez, Aitor
  • Rodríguez-San Pedro, Andrea
  • Casquero-Veiga, Marta
  • Cossío, Unai
  • Arias-Ramos, Nuria
  • Gutiérrez, Lucía
  • Romero-Sanz, Eduardo
  • Luján-Rodríguez, Víctor Manuel
  • Cerón, Carlos
  • Oteo, Marta
  • González-Paredes, Ana
  • López-Larrubia, Pilar
  • Rosales, Rafael T. M. de
  • Cortés-Canteli, Marta
  • Morcillo, Miguel A.
  • Ruíz-Cabello, Jesús
  • Pellico, Juan
  • Herranz, Fernando
Data availability: The datasets generated and/or analyzed during the current study are very large and complex, and are not easily shared via public repositories, but they are fully available from the corresponding author upon reasonable request., Radiopharmaceuticals that combine diagnostic and therapeutic isotopes are at the forefront of novel cancer treatments. A crucial element is the method of attaching radioisotopes to biomolecules using chelator-based techniques that are widely used clinically. Selection from available chelators is essential because this choice influences the physicochemical and biological characteristics of the final radiopharmaceutical. Numerous chelators exist because none fulfill all ideal conditions: rapid and complete binding to radiometals at low concentrations and with metallic impurities, high thermodynamic and kinetic stability in vivo, easy bioconjugation, and, key for this work, achieving these for many radiometals from the growing list of medical isotopes. We demonstrate how nanotechnology may change this. Ten nano-radiotracers were synthesized, incorporating radiometals such as 68Ga, 64Cu, 89Zr, 99mTc, 201Tl, 111In, 67Ga, 177Lu, 223Ra, and 225Ac into the nanoparticle core. The versatility of the platform was demonstrated through proof-of-concept experiments, including passive targeting in glioblastoma, active targeting of thrombosis, intratumoral radiotherapy in glioblastoma, and renal clearance optimization. This nanotracer addresses traditional challenges in radiopharmaceutical development, offering a single platform with consistent physicochemical and biological properties regardless of the radioisotope used for robust diagnostic and therapeutic applications., The authors thank funding from the Spanish Ministry of Science and Innovation (PDC2022-133493-100, RED2022-134299-T, PID2019-104059RB-100), Comunidad de Madrid (P2022/BMD-7333) and Conexion Nanomedicina CSIC. The authors thank the Sebastián Cerdán Biomedical NMR Facility of IIBM for their technical support. J. P. acknowledges financial support from the Ramon y Cajal program (Grant No. RYC2023-043157-I) funded by the MCIN/AEI/10.13039/501100011033 and the ESF “Investing in your future”., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Periodic table screening for enhanced positive contrast in MRI and <i>in vivo</i> uptake in glioblastoma

  • Herraiz, Aitor
  • Morales, M. Puerto
  • Martínez-Parra, Lydia
  • Arias-Ramos, Nuria
  • López-Larrubia, Pilar
  • Gutiérrez, Lucía
  • Mejías, Jesús
  • Díaz-Ufano, Carlos
  • Ruiz-Cabello, Jesús
  • Herranz, Fernando
The quest for nanomaterial-based imaging probes that can provide positive contrast in MRI is fueled by the necessity of developing novel diagnostic applications with potential for clinical translation that current gold standard probes cannot provide. Although interest in nanomaterials for positive contrast has increased in recent years, their study is less developed than that of traditional negative contrast probes in MRI. In our search for new magnetic materials with enhanced features as positive contrast probes for MRI, we decided to explore the chemical space to comprehensively analyze the effects of different metals on the performance of iron oxide nanomaterials already able to provide positive contrast in MRI. To this end, we synthesized 30 different iron oxide-based nanomaterials. Thorough characterization was performed, including multivariate analysis, to study the effect of different variables on their relaxometric properties. Based on these results, we identified the best combination of metals for in vivo imaging and tested them in different experiments. First, we tested its performance on magnetic resonance angiography using a concentration ten times lower than that clinically approved for Gd. Finally, we studied the capability of these nanomaterials to cross the affected blood–brain barrier in a glioblastoma model. The results showed that the selected nanomaterials provided excellent positive contrast at large magnetic field and were able to accumulate at the tumor site, highlighting the affected tissue
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis

  • Pellico, J
  • Fernandez-Barahona, I
  • Ruiz-Cabello, J
  • Gutierrez, L
  • Munoz-Hernando, M
  • Sanchez-Guisado, MJ
  • Aiestaran-Zelaia, I
  • Martinez-Parra, L
  • Rodriguez, I
  • Bentzon, J
  • Herranz, F
Vascular microcalcifications are associated with atherosclerosis plaque instability and, therefore, to increased mortality. Because of this key role, several imaging probes have been developed for their in vivo identification. Among them, [F-18]FNa is the gold standard, showing a large uptake in the whole skeleton by positron emission tomography. Here, we push the field toward the combined anatomical and functional early characterization of atherosclerosis. For this, we have developed hydroxyapatite (HAP)-multitag, a bisphosphonatefunctionalized Ga-68 core-doped magnetic nanoparticle showing high affinity toward most common calcium salts present in microcalcifications, particularly HAP. We characterized this interaction in vitro and in vivo, showing a massive uptake in the atherosclerotic lesion identified by positron emission tomography (PET) and positive contrast magnetic resonance imaging (MRI). In addition, this accumulation was found to be dependent on the calcification progression, with a maximum uptake in the microcalcification stage. These results confirmed the ability of HAP-multitag to identify vascular calcifications by PET/(T-1)MRI during the vulnerable stages of the plaque progression.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A single-step radiolabeling strategy for PET, SPECT, and therapeutic radionuclides using nanoparticles as a universal chelator

  • Herraiz, Aitor
  • Rodríguez-San-Pedro, Andrea
  • Casquero-Veiga, Marta
  • Cossío, Unai
  • Arias-Ramos, Nuria
  • Gutiérrez, Lucía
  • Romero-Sanz, Eduardo
  • Luján-Rodríguez, Víctor Manuel
  • Cerón, Carlos
  • Oteo, Marta
  • González-Paredes, Ana
  • López-Larrubia, Pilar
  • Rosales, Rafael T. M. de
  • Cortes-Canteli, Marta
  • Morcillo, Miguel A.
  • Ruiz-Cabello, Jesús
  • Pellico, Juan
  • Herranz, Fernando
Radiopharmaceuticals that combine diagnostic and therapeutic isotopes are at the forefront of novel cancer treatments. A crucial element is the method of attaching radioisotopes to biomolecules using chelator-based techniques that are widely used clinically. Selection from available chelators is essential because this choice influences the physicochemical and biological characteristics of the final radiopharmaceutical. Numerous chelators exist because none fulfill all ideal conditions: rapid and complete binding to radiometals at low concentrations and with metallic impurities, high thermodynamic and kinetic stability in vivo, easy bioconjugation, and, key for this work, achieving these for many radiometals from the growing list of medical isotopes. We demonstrate how nanotechnology may change this. Ten nano-radiotracers were synthesized, incorporating radiometals such as 68Ga, 64Cu, 89Zr, 99mTc, 201Tl, 111In, 67Ga, 177Lu, 223Ra, and 225Ac into the nanoparticle core. The versatility of the platform was demonstrated through proof-of-concept experiments, including passive targeting in glioblastoma, active targeting of thrombosis, intratumoral radiotherapy in glioblastoma, and renal clearance optimization. This nanotracer addresses traditional challenges in radiopharmaceutical development, offering a single platform with consistent physicochemical and biological properties regardless of the radioisotope used for robust diagnostic and therapeutic applications.
Docta Complutense
Publication Artículo científico (JournalArticle)

HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis

  • Juan Pellico
  • Irene Fernández Barahona
  • Ruiz-Cabello Osuna, Jesús
  • Lucía Gutiérrez
  • María Muñoz-Hernando
  • María J. Sánchez Guisado
  • Irati Aiestaran-Zelaia
  • Lydia Martínez-Parra
  • Rodríguez Ramírez De Arellano, Ignacio
  • Jacob Bentzon
  • Fernando Herranz
Vascular microcalcifications are associated with atherosclerosis plaque instability and, therefore, to increased mortality. Because of this key role, several imaging probes have been developed for their in vivo identification. Among them, [18F]FNa is the gold standard, showing a large uptake in the whole skeleton by positron emission tomography. Here, we push the field toward the combined anatomical and functional early characterization of atherosclerosis. For this, we have developed hydroxyapatite (HAP)-multitag, a bisphosphonatefunctionalized 68Ga core-doped magnetic nanoparticle showing high affinity toward most common calcium salts present in microcalcifications, particularly HAP. We characterized this interaction in vitro and in vivo, showing a massive uptake in the atherosclerotic lesion identified by positron emission tomography (PET) and positive contrast magnetic resonance imaging (MRI). In addition, this accumulation was found to be dependent on the calcification progression, with a maximum uptake in the microcalcification stage. These results confirmed the ability of HAP-multitag to identify vascular calcifications by PET/(T1)MRI during the vulnerable stages of the plaque progression.